- Banco do Brasil reported an adjusted net income of R$9.58 billion for the 4th quarter, which is a 1.5% increase compared to the same period last year.
- The reported adjusted net income exceeded estimates, which were set at R$9.41 billion.
- The bank’s loan portfolio expanded to R$1.3 trillion.
- The Tier 1 Capital Ratio was reported at 12.7%, slightly below the estimate of 13.4%.
- Analysts’ recommendations for Banco do Brasil’s stock include 9 buys, 6 holds, and 1 sell.
“`
A look at Banco do Brasil Smart Scores
| Factor | Score | Magnitude |
|---|---|---|
| Value | 4 | |
| Dividend | 5 | |
| Growth | 4 | |
| Resilience | 2 | |
| Momentum | 5 | |
| OVERALL SMART SCORE | 4.0 |
Smart Score is a compound score for the Company indicating its overall outlook. It is derived by taking an equally weighted average of underlying Factor scores computed by Smartkarma
Based on the Smartkarma Smart Scores, Banco do Brasil is positioned for a positive long-term outlook. With high scores in Dividend and Momentum, the company shows strength in both rewarding investors consistently and maintaining a strong market performance. Additionally, solid scores in Value and Growth indicate a strong fundamental and growth potential, respectively. However, the lower score in Resilience suggests a need for caution, as the company may face challenges in certain aspects of its operations.
Banco do Brasil S.A., known for attracting deposits and providing a range of banking services, including loans, asset management, insurance, and Internet banking, is showing promising signs for investors. The company’s focus on dividends and market momentum, along with its fundamental value and growth prospects, bode well for its future performance. Despite some resilience concerns, Banco do Brasil presents as a potential investment opportunity for those seeking exposure to the banking sector.
Disclaimer: This article by Smartkarma is general in nature and based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. Note that our articles may not factor in the latest price-sensitive company announcements or qualitative material.
While all reasonable care has been taken in the preparation, Smartkarma makes no assurance about the accuracy of any generated data or content. All content is indicative only and should be independently checked for accuracy and confirmed before use. Smartkarma accepts no responsibility for any loss or damage caused as a result of any inaccuracy or error within the Lab online tools or generated data.
Have feedback on this article? Concerned about the content? Get in touch with us directly.
💡 Before it’s here, it’s on Smartkarma
Sign Up for Free
The Smartkarma Preview Pass is your entry to the Independent Investment Research Network
- ✓ Unlimited Research Summaries
- ✓ Personalised Alerts
- ✓ Custom Watchlists
- ✓ Company Analytics and News
- ✓ Events & Webinars
